Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


07.05.2018

5 Anticancer Res
5 BMC Cancer
1 Gastroenterology
1 Gut
2 Int J Cancer
4 Lancet Gastroenterol Hepatol
1 PLoS One
1 World J Surg


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. MARUYAMA S, Furuya S, Shiraishi K, Shimizu H, et al
    Podoplanin Expression as a Prognostic Factor in Gastric Cancer.
    Anticancer Res. 2018;38:2717-2722.
    PubMed     Text format     Abstract available

  2. MONDLANE G, Ureba A, Gubanski M, Lind PA, et al
    Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams.
    Anticancer Res. 2018;38:2619-2625.
    PubMed     Text format     Abstract available

  3. HWANG GY, Baek DW, Cho HJ, Lee SJ, et al
    Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.
    Anticancer Res. 2018;38:3151-3156.
    PubMed     Text format     Abstract available

  4. KIUCHI J, Komatsu S, Kosuga T, Kubota T, et al
    Long-term Postoperative Nutritional Status Affects Prognosis Even After Infectious Complications in Gastric Cancer.
    Anticancer Res. 2018;38:3133-3138.
    PubMed     Text format     Abstract available

  5. IWABU J, Namikawa T, Tsuda S, Kitagawa H, et al
    Successful Distal Gastrectomy for Gastric Cancer with Child-Pugh Class B Alcoholic Liver Cirrhosis.
    Anticancer Res. 2018;38:3085-3087.
    PubMed     Text format     Abstract available


    BMC Cancer

  6. HUANG Z, Liu Y, Yang C, Li X, et al
    Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
    BMC Cancer. 2018;18:515.
    PubMed     Text format     Abstract available

  7. HSIEH YY, Tung SY, Pan HY, Yen CW, et al
    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
    BMC Cancer. 2018;18:508.
    PubMed     Text format     Abstract available

  8. HONG SA, Yoo SH, Lee HH, Sun S, et al
    Prognostic value of Dickkopf-1 and ss-catenin expression in advanced gastric cancer.
    BMC Cancer. 2018;18:506.
    PubMed     Text format     Abstract available

  9. LINK H, Angele M, Schuller M, Ganschow P, et al
    Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
    BMC Cancer. 2018;18:483.
    PubMed     Text format     Abstract available

  10. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    PubMed     Text format     Abstract available


    Gastroenterology

  11. ZHANG X, Li M, Chen S, Hu J, et al
    Endoscopic Screening in Asian Countries Associates With Reduced Gastric Cancer Mortality: A Meta-Analysis and Systematic Review.
    Gastroenterology. 2018 Apr 30. pii: S0016-5085(18)30487.
    PubMed     Text format     Abstract available


    Gut

  12. SEIDLITZ T, Merker SR, Rothe A, Zakrzewski F, et al
    Human gastric cancer modelling using organoids.
    Gut. 2018 Apr 27. pii: gutjnl-2017-314549. doi: 10.1136/gutjnl-2017-314549.
    PubMed     Text format     Abstract available


    Int J Cancer

  13. MIZUGUCHI A, Takai A, Shimizu T, Matsumoto T, et al
    Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
    Int J Cancer. 2018 May 1. doi: 10.1002/ijc.31578.
    PubMed     Text format     Abstract available

  14. SHAO L, Li P, Ye J, Chen J, et al
    Risk of gastric cancer among patients with gastric intestinal metaplasia.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31571.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  15. BYRNE BE, Rogers CA, Blazeby JM
    The end of bursectomy for gastric cancer?
    Lancet Gastroenterol Hepatol. 2018 Apr 27. pii: S2468-1253(18)30135.
    PubMed     Text format    

  16. FEWINGS E, Larionov A, Redman J, Goldgraben MA, et al
    Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
    Lancet Gastroenterol Hepatol. 2018 Apr 26. pii: S2468-1253(18)30079.
    PubMed     Text format     Abstract available

  17. CARVAJAL-CARMONA LG
    PALB2 as a familial gastric cancer gene: is the wait over?
    Lancet Gastroenterol Hepatol. 2018 Apr 26. pii: S2468-1253(18)30120.
    PubMed     Text format    

  18. KUROKAWA Y, Doki Y, Mizusawa J, Terashima M, et al
    Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2018 Apr 27. pii: S2468-1253(18)30090.
    PubMed     Text format     Abstract available


    PLoS One


  19. Correction: Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.
    PLoS One. 2018;13:e0197013.
    PubMed     Text format     Abstract available


    World J Surg

  20. SEO HS, Song KY, Jung YJ, Park SM, et al
    Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis.
    World J Surg. 2018 May 1. pii: 10.1007/s00268-018-4635.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: